CFO & Executive Vice President, CNSI
David Adams’ recent achievement as CFO was his significant contribution in the December 2021 acquisition of CNSI by Carlyle from private equity firm Alvarez & Marsal Capital Partners.
“Dave played a critical role in helping plan and execute the successful transaction with Carlyle this past December,” said Todd Stottlemyer, CNSI CEO. “His M&A and broad industry experience were instrumental to the success of the sale.”
CNSI’s acquisition was the largest dollar sale in AMCP’s fund. The team at CNSI closed 2021 with double-digit revenue growth and had consistently grown by double digits during AMCP’s ownership, reaching approximately $200 million in revenue by focusing on organic growth and exquisite execution for CNSI state and federal health care clients.
The team’s timely and accurate financial reporting was critical to CNSI’s acquisition last year, but that only tells half the story and is basic “blocking and tackling,” Adams said.
“The team continues to redefine what and how we do things to be able to scale with CNSI,” he said. “In addition to our successful year on the balance sheet, the CFO organization (finance and accounting, procurement, contracts and facilities) was one of the highest scoring CNSI teams in the company’s 2021 Gallup Employee Engagement survey. We live by our core value of ‘One Team, #ONECNSI.’”
In 2022, CNSI is heavily focused on its 5-year goal to achieve more than $1 billion in annual revenue through strong organic growth and strategic acquisitions.
The company’s journey to be the market leader in the public sector health care technology space is well underway. The team will be very active in 2022 supporting significant organic growth and participating in strategic acquisitions.
“Our operations, technology and sales teams are clearly the driving forces behind CNSI’s financial achievements,” Adams said. “The CFO organization’s support of these functions ensures that CNSI continues to be a trusted partner to government agencies. We’re united in a common goal of exquisite execution as we empower the delivery of public sector health care.”